1
|
Kettisen K, Nyblom M, Smeds E, Fago A, Bülow L. Structural and oxidative investigation of a recombinant high-yielding fetal hemoglobin mutant. Front Mol Biosci 2023; 10:1133985. [PMID: 37006610 PMCID: PMC10060959 DOI: 10.3389/fmolb.2023.1133985] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2023] [Accepted: 03/01/2023] [Indexed: 03/18/2023] Open
Abstract
Human fetal hemoglobin (HbF) is an attractive starting protein for developing an effective agent for oxygen therapeutics applications. This requires that HbF can be produced in heterologous systems at high levels and in a homogeneous form. The introduction of negative charges on the surface of the α-chain in HbF can enhance the recombinant production yield of a functional protein in Escherichia coli. In this study, we characterized the structural, biophysical, and biological properties of an HbF mutant carrying four additional negative charges on each α-chain (rHbFα4). The 3D structure of the rHbFα4 mutant was solved with X-ray crystallography at 1.6 Å resolution. Apart from enabling a higher yield in recombinant protein production in E. coli, we observed that the normal DNA cleavage activity of the HbF was significantly lowered, with a four-time reduced rate constant for the rHbFα4 mutant. The oxygen-binding properties of the rHbFα4 mutant were identical to the wild-type protein. No significant difference between the wild-type and rHbFα4 was observed for the investigated oxidation rates (autoxidation and H2O2-mediated ferryl formation). However, the ferryl reduction reaction indicated some differences, which appear to be related to the reaction rates linked to the α-chain.
Collapse
Affiliation(s)
- Karin Kettisen
- Pure and Applied Biochemistry, Department of Chemistry, Lund University, Lund, Sweden
| | - Maria Nyblom
- Lund Protein Production Platform, Department of Biology, Lund University, Lund, Sweden
| | - Emanuel Smeds
- Infection Medicine, Department of Clinical Sciences, Lund University, Lund, Sweden
- Anesthesiology and Intensive Care, Department of Clinical Sciences, Lund University, Lund, Sweden
| | - Angela Fago
- Zoophysiology, Department of Biology, Aarhus University, Aarhus, Denmark
| | - Leif Bülow
- Pure and Applied Biochemistry, Department of Chemistry, Lund University, Lund, Sweden
- *Correspondence: Leif Bülow,
| |
Collapse
|
2
|
Kettisen K, Bülow L. Introducing Negatively Charged Residues on the Surface of Fetal Hemoglobin Improves Yields in Escherichia coli. Front Bioeng Biotechnol 2021; 9:721794. [PMID: 34552916 PMCID: PMC8450383 DOI: 10.3389/fbioe.2021.721794] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2021] [Accepted: 08/20/2021] [Indexed: 11/14/2022] Open
Abstract
Fetal hemoglobin (HbF) has been developed into an important alternative protein for oxygen therapeutics. Such applications require extensive amounts of proteins, which only can be achieved via recombinant means. However, the expression of vertebrate hemoglobins in heterologous hosts is far from trivial. There are several issues that need to be dealt with. These include, among others, the solubility of the globin chains, equimolar expression of the globin chains, and access to high levels of free heme. In this study, we examined the impact of introducing negative charges on the surface of HbF. Three different HbF mutants were examined, carrying four additional negative charges on the α-subunit (rHbFα4), two additional negative charges on the γ-subunit (rHbFγ2) or a combination of these (rHbFα4/γ2). The increase in negative surface charge in these HbF mutants required the development of an alternate initial capture step in the downstream purification procedures. For the rHbFα4 mutant, we achieved a significantly enhanced yield of purified HbF with no apparent adverse effects on Hb functionality. However, the presence of non-functional Hb portions in the rHbFγ2 and rHbFα4/γ2 samples reduced the yields significantly for those mutants and indicated an imbalanced expression/association of globin chains. Furthermore, the autoxidation studies indicated that the rHbFγ2 and rHbFα4/γ2 mutants also were less oxidatively stable than rHbFα4 and wt rHbF. The study further verified the need for an improved flask culture protocol by optimizing cultivation parameters to enable yield-improving qualities of surface-located mutations.
Collapse
Affiliation(s)
- Karin Kettisen
- Division of Pure and Applied Biochemistry, Department of Chemistry, Lund University, Lund, Sweden
| | - Leif Bülow
- Division of Pure and Applied Biochemistry, Department of Chemistry, Lund University, Lund, Sweden
| |
Collapse
|
3
|
Horri-Naceur A, Timson DJ. In Silico Analysis of the Effects of Point Mutations on α-Globin: Implications for α-Thalassemia. Hemoglobin 2020; 44:89-103. [PMID: 32420790 DOI: 10.1080/03630269.2020.1739067] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Abstract
Hemoglobinopathies are inherited diseases that impair the structure and function of the oxygen-carrying pigment hemoglobin (Hb). Adult Hb consists of two α and two β subunits. α-Thalassemia (α-thal) affects the genes that code for the α-globin chains, HBA1 and HBA2. Mutations can result in asymptomatic, mild or severe outcomes depending on several factors, such as mutation type, number of mutations and the location at which they occur. PredictSNP was used to estimate whether every possible single nucleotide polymorphism (SNP) would have a neutral or deleterious effect on the protein. These results were then used to create a plot of predicted tolerance to change for each residue in the protein. Tolerance to change was negatively correlated with the residue's sequence conservation score. The PredictSNP data were compared to clinical reports of 110 selected variants in the literature. There were 29 disagreements between the two data types. Some of these could be resolved by considering the role of the affected residue in binding other molecules. The three-dimensional structures of some of these variant proteins were modeled. These models helped explain variants which affect heme binding. We predict that where a point mutation alters a residue that is intolerant to change, is well conserved and or involved in interactions, it is likely to be associated with disease. Overall, the data from this study could be used alongside biochemical and clinical data to assess novel α-globin variants.
Collapse
Affiliation(s)
- Agathe Horri-Naceur
- School of Pharmacy and Biomolecular Sciences, University of Brighton, Brighton, East Sussex, UK
| | - David J Timson
- School of Pharmacy and Biomolecular Sciences, University of Brighton, Brighton, East Sussex, UK
| |
Collapse
|
4
|
Kimura EM, Oliveira DM, Jorge SE, Ribeiro DM, Zaccariotto TR, Santos MNN, Almeida V, Albuquerque DM, Costa FF, Sonati MDF. Investigating alpha-globin structural variants: a retrospective review of 135,000 Brazilian individuals. Rev Bras Hematol Hemoter 2015; 37:103-8. [PMID: 25818820 PMCID: PMC4382568 DOI: 10.1016/j.bjhh.2015.01.005] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2014] [Accepted: 09/30/2014] [Indexed: 12/04/2022] Open
Abstract
Background Brazil has a multiethnic population with a high diversity of hemoglobinopathies. While screenings for beta-globin mutations are far more common, alterations affecting alpha-globin genes are usually more silent and less well known. The aim of this study was to describe the results of a screening program for alpha-globin gene mutations in a representative sample of the Southeastern Brazilian population. Methods A total of 135,000 individuals, including patients with clinical suspicion of hemoglobinopathies and their family members, randomly chosen individuals submitted to blood tests and blood donors who were abnormal hemoglobin carriers were analyzed. The variants were screened by alkaline and acid electrophoreses, isoelectric focusing and cation-exchange high performance liquid chromatography (HPLC) and the abnormal chains were investigated by reverse-phase high performance liquid chromatography (RP-HPLC). Mutations were identified by molecular analyses, and the oxygen affinity, heme–heme cooperativity and Bohr effect of the variants were evaluated by functional tests. Results Four new and 22 rare variants were detected in 98 families. Some of these variants were found in co-inheritance with other hemoglobinopathies. Of the rare hemoglobins, Hasharon, Stanleyville II and J-Rovigo were the most common, the first two being S-like and associated with alpha-thalassemia. Conclusion The variability of alpha-globin alterations reflects the high degree of racial miscegenation and an intense internal migratory flow between different Brazilian regions. This diversity highlights the importance of programs for diagnosing hemoglobinopathies and preventing combinations that may lead to important clinical manifestations in multiethnic populations.
Collapse
Affiliation(s)
- Elza Miyuki Kimura
- Department of Clinical Pathology, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, SP, Brazil; National Institute of Blood Science and Technology, National Council for Scientific and Technological Development (CNPq), Ministry of Science and Technology (MCT), Brazil
| | - Denise Madureira Oliveira
- Department of Clinical Pathology, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, SP, Brazil; National Institute of Blood Science and Technology, National Council for Scientific and Technological Development (CNPq), Ministry of Science and Technology (MCT), Brazil
| | - Susan Elisabeth Jorge
- Department of Clinical Pathology, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, SP, Brazil; National Institute of Blood Science and Technology, National Council for Scientific and Technological Development (CNPq), Ministry of Science and Technology (MCT), Brazil
| | - Daniela Maria Ribeiro
- Department of Clinical Pathology, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, SP, Brazil; National Institute of Blood Science and Technology, National Council for Scientific and Technological Development (CNPq), Ministry of Science and Technology (MCT), Brazil
| | - Tânia Regina Zaccariotto
- Department of Clinical Pathology, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, SP, Brazil; National Institute of Blood Science and Technology, National Council for Scientific and Technological Development (CNPq), Ministry of Science and Technology (MCT), Brazil
| | - Magnun Nueldo Nunes Santos
- Department of Clinical Pathology, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, SP, Brazil; National Institute of Blood Science and Technology, National Council for Scientific and Technological Development (CNPq), Ministry of Science and Technology (MCT), Brazil
| | - Vanessa Almeida
- Department of Clinical Pathology, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, SP, Brazil; National Institute of Blood Science and Technology, National Council for Scientific and Technological Development (CNPq), Ministry of Science and Technology (MCT), Brazil
| | - Dulcinéia Martins Albuquerque
- National Institute of Blood Science and Technology, National Council for Scientific and Technological Development (CNPq), Ministry of Science and Technology (MCT), Brazil; Hematology and Hemotherapy Center, University of Campinas (UNICAMP), Campinas, SP, Brazil
| | - Fernando Ferreira Costa
- National Institute of Blood Science and Technology, National Council for Scientific and Technological Development (CNPq), Ministry of Science and Technology (MCT), Brazil; Hematology and Hemotherapy Center, University of Campinas (UNICAMP), Campinas, SP, Brazil
| | - Maria de Fátima Sonati
- Department of Clinical Pathology, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, SP, Brazil; National Institute of Blood Science and Technology, National Council for Scientific and Technological Development (CNPq), Ministry of Science and Technology (MCT), Brazil.
| |
Collapse
|
5
|
|
6
|
|
7
|
|
8
|
|
9
|
|
10
|
|
11
|
|
12
|
|
13
|
International Hemoglobin Information Center Policies - IHIC. Hemoglobin 2009. [DOI: 10.3109/03630268108991816] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
14
|
|
15
|
|
16
|
Oron-Karni V, Filon D, Shifrin Y, Fried E, Pogrebijsky G, Oppenheim A, Rund D. Diversity of alpha-globin mutations and clinical presentation of alpha-thalassemia in Israel. Am J Hematol 2000; 65:196-203. [PMID: 11074535 DOI: 10.1002/1096-8652(200011)65:3<196::aid-ajh4>3.0.co;2-8] [Citation(s) in RCA: 37] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Alpha-thalassemia is among the world's most common single gene disorders, caused primarily by gene deletions. In Israel, where alpha(o)-trait thalassemia is uncommon, it is of particular importance because of its phenotypic interactions with beta-thalassemia in hetero- and homozygotes. In a study of 232 individuals referred for molecular evaluation of anemia, 303 chromosomes carried alpha-globin gene abnormalities; 6 gene rearrangements and 11 point mutations were identified. This unexpected heterogeneity is in part due to the many ethnic subgroups represented by these patients. Our findings include nine unique Israeli alleles, 3 of which are described here for the first time. An equal number of point mutations was found in the alpha2-globin gene as compared to alpha1. A threonine deletion in codon 39 of the alpha1-globin gene, found frequently in Arabs, is unique to Israel and probably represents one of several indigenous alleles. Among Arabs, point mutations were more frequent than large deletions. Surprisingly, in Ashkenazi Jews, who resided for many centuries in a nonmalarial environment, a single alpha-globin gene deletion -alpha(3.7) was found in many cases. The clinical presentation of individuals carrying two or more alpha-globin lesions was highly variable. In general, the severity correlated inversely with the number of functional alpha-globin genes. In some cases, impairment of two alpha-globin genes by point mutations led to a thalassemia-intermedia-like picture which could be misdiagnosed as beta-thalassemia. We conclude that alpha-thalassemia is phenotypically and genotypically more heterogeneous than previously recognized. DNA analysis is invaluable as it provides a specific diagnosis and enables reliable genetic counseling.
Collapse
Affiliation(s)
- V Oron-Karni
- Hematology Department, Hebrew University--Hadassah Medical School and Hadassah University Hospital, Ein Kerem, Jerusalem, Israel
| | | | | | | | | | | | | |
Collapse
|
17
|
|
18
|
|
19
|
|
20
|
Wajcman H, Gombaud-Saintonge G, Galacteros F, Martha M, Vertongen F. Hb Belliard [alpha 56(E5)Lys----Asn] a new fast-moving alpha chain variant found in a subject of Spanish origin. Hemoglobin 1989; 13:157-62. [PMID: 2737910 DOI: 10.3109/03630268908998065] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Affiliation(s)
- H Wajcman
- INSERM U299, Hôpital de Bicêtre, France
| | | | | | | | | |
Collapse
|
21
|
Abstract
A survey of the various hemoglobinopathies in Israel is reported. The information was supplied from 13 hematology services throughout the country and from the Ministry of Health. The common hemoglobinopathies encountered were the thalassemias and sickle cell anemia. In addition, hemoglobin C and O Arab were found in isolated communities. Sporadic cases of hemoglobin Hasharon, hemoglobin D, hemoglobin NYU were also found. The thalassemic patients originated mainly from Kurdistan, Yemen and Iraq, while the sickle cell patients were mainly Moslem Arabs or Bedouins.
Collapse
|
22
|
|
23
|
|